Novartis Closer to Selling Copy of Amgen's Neupogen

A federal appeals court in Washington denied Amgen Inc.’s request for a temporary injunction to block Novartis AG from selling a copycat version of the blockbuster drug Neupogen in the U.S.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news